ENDRA Life Sciences (NDRA) Return on Capital Employed (2017 - 2026)
ENDRA Life Sciences (NDRA) reported Return on Capital Employed of 77.57% for Q1 2026, up 21530.0% year-over-year from N/an in Q1 2025, and down 13.43% quarter-over-quarter from 68.39% in Q4 2025.
ENDRA Life Sciences (NDRA) Return on Capital Employed (2017 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has 10 years of Return on Capital Employed data on file, last reported at 77.57% in Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 77.57%, up 21530.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 77.57% (up 21530.0% YoY), and the FY2025 annual result was 43.38%, up 17305.0% from the prior year.
- Return on Capital Employed fell to 77.57% in Q1 2026 per NDRA's latest filing, from 68.39% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 68.39% in Q4 2025 and troughed at 532.16% in Q3 2025.
- A 5-year average of 190.53% and a median of 167.65% in 2023 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2025 and 2026: Return on Capital Employed tumbled 43935 bps in 2025, then jumped 21530 bps in 2026.
- A 5-year view of Return on Capital Employed shows it stood at 144.51% in 2022, then fell by 16 bps to 167.65% in 2023, then retreated by 11 bps to 186.17% in 2024, then surged by 63 bps to 68.39% in 2025, then dropped by 13 bps to 77.57% in 2026.
- Business Quant data shows NDRA's Return on Capital Employed at 77.57% in Q1 2026, 68.39% in Q4 2025, and 532.16% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 4.82% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 8.12% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 6.26% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 67.98% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 14.57% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -3.63% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 10.24% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 16.90% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 45.73% |
| 10 | ENDRA Life Sciences | 5.24 Mn | 4.89 Mn | - | -77.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -77.57% |
| Dec 31, 2025 | -68.39% |
| Sep 30, 2025 | -532.16% |
| Jun 30, 2025 | -355.49% |
| Mar 31, 2025 | -292.88% |
| Dec 31, 2024 | -186.17% |
| Sep 30, 2024 | -92.80% |
| Jun 30, 2024 | -149.94% |
| Mar 31, 2024 | -220.90% |
| Dec 31, 2023 | -167.65% |
| Sep 30, 2023 | -197.88% |
| Jun 30, 2023 | -214.04% |
| Mar 31, 2023 | -215.92% |
| Dec 31, 2022 | -144.51% |
| Sep 30, 2022 | -106.56% |
| Jun 30, 2022 | -104.55% |
| Mar 31, 2022 | -111.66% |
| Dec 31, 2021 | -91.62% |
| Sep 30, 2021 | -72.65% |
| Jun 30, 2021 | -68.68% |